Ablation Systems

This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated  by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems

Cardiva Medical Announces Completion of the AMBULATE Pivotal Trial
News | Vascular Closure Devices | May 10, 2018

May 10, 2018 — Cardiva Medical Inc. announced the completion of the AMBULATE pivotal trial, one of several...

Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Technology | Ablation Systems | May 08, 2018

May 8, 2018 — Biosense Webster Inc. announced its Carto Vizigo Bi-directional Guiding Sheath is now available in the...

Stereotaxis and Acutus Medical Announce Strategic Collaboration
News | Ablation Systems | May 04, 2018

May 4, 2018 — Stereotaxis and Acutus Medical announced a strategic collaboration to integrate the Stereotaxis Niobe...

The Abbott Advisor HD Grid Mapping Catheter, Sensor Enabled, allows high density electro mapping for transcatheter EP cardiac ablation procedures.
Technology | EP Mapping and Imaging Systems | May 03, 2018

May 3, 2018 — The U.S. Food and Drug Administration (FDA) has granted market clearance for the Abbott Advisor HD...

Medtronic Cryoballoon Shows Positive Results for Patients With Persistent Atrial Fibrillation
News | Ablation Systems | April 12, 2018

April 12, 2018 — Medtronic plc announced one-year results from the CRYO4PERSISTENT AF study of...

Boston Scientific Acquires Securus Medical Group Inc.
News | Ablation Systems | April 04, 2018

April 4, 2018 — Boston Scientific Corp. announced the acquisition of Securus Medical Group Inc., a privately-held...

Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018

March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who...

Imricor Completes Enrollment for Clinical Study on Vision-MR Ablation Catheter
News | Interventional Radiology | January 23, 2018

January 23, 2018 – Imricor Medical Systems announced the completion of enrollment for the clinical study to evaluate...

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled
Technology | EP Mapping and Imaging Systems | January 19, 2018

January 19, 2018 — Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping...

Boston Scientific's Apama multi-electrode ablation balloon to treat atrial fibrillation.

Boston Scientific's Apama multi-electrode ablation balloon to treat atrial fibrillation. The technology allows different energies to be used for each electrode to prevent damage to the esophagus or other underlying critical structures. 

Feature | Atrial Fibrillation | January 15, 2018 | Dave Fornell

The development of atrial fibrillation (AFib or AF) ablation technologies over the past 20 years has been a constant...

Stereotaxis Receives Regulatory Approval of e-Contact Module in Canada
Technology | Ablation Systems | December 08, 2017

December 7, 2017 — Stereotaxis Inc. announced it has received regulatory clearance from Health Canada for its e-...

Acutus dipole density EP mapping for ablation procedures.

The FDA recently cleared high-speed Acutus Medical's AcQMap High Resolution image and mapping system and the AcQMap 3-D Imaging and Mapping Catheter.  detects and displays both standard voltage-based and higher resolution dipole density (charge-source) maps. The system combines ultrasound anatomy construction with an ability to map the electrical-conduction of each heartbeat to identify complex arrhythmias across the entire atrial chamber. Following each ablation treatment, the heart can be re-mapped in seconds to continually visualize any changes from the prior mapping.

 

 

Feature | Atrial Fibrillation | November 07, 2017

November 7, 2017 — Here is an aggregated list of articles detailing the latest clinical data and new device...

Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology
Technology | EP Mapping and Imaging Systems | October 24, 2017

October 24, 2017 — Acutus Medical announced that the U.S. Food and Drug Administration (FDA) has cleared the AcQMap ...

CardioFocus Announces European CE Mark Approval of HeartLight Excalibur Balloon
Technology | Ablation Systems | October 10, 2017

October 10, 2017 — CardioFocus Inc. recently announced the European CE Mark approval of the HeartLight Excalibur...

Overlay Init